Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Cancer mortality at an all time low finds report

In a new Annual Report to the Nation on the Status of Cancer, researchers have found that death rates due to cancer have declined over among all age groups and both sexes in the United States between 1999 and 2016.

30 May 2019

Study: Type 2 diabetes linked to elevated risk of several cancers

A new Journal of Diabetes study from China, which has the highest number of people with diabetes among all countries, found that type 2 diabetes was linked with an elevated risk of 11 types of cancer in men and 13 types of cancer in women.

9 May 2019

Pediatric patients undergoing thyroid surgery have better outcomes at high-volume centers

New research recently published in the Journal of Pediatric Surgery found that post-operative success rates of pediatric thyroid patients, particularly children who require a thyroidectomy, correlate with the institution's patient volume.

4 Apr 2019

$Breakthrough alpha-ray treatment of iodine-refractory thyroid cancer with multiple metastases$

Breakthrough alpha-ray treatment of iodine-refractory thyroid cancer with multiple metastases

For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%.

2 Apr 2019

Study highlights debt and work-related impairments for young adult cancer survivors

Student loans aren't the only reason young adults end up in debt. One of the largest-ever studies of work-related risks in young adult cancer survivors finds that of 872 survivors, 14.4 percent borrowed more than $10,000 and 1.5 percent said they or their family had filed for bankruptcy as a direct result of illness or treatment.

26 Feb 2019

An essential reference for diagnostic ultrasonography and biopsy of the thyroid gland

The book provides the reader essential information on how to 1) distinguish between normal and abnormal thyroid sonograms, 2) differentiate low suspicion for malignancy thyroid nodules from sonographically high suspicion nodules, 3) evaluate cervical lymph nodes and parathyroid glands, and 4) examine post-thyroidectomy patients with differentiated thyroid cancer.

23 Jan 2019

Study: Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors

New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of solid tumors many years later.

17 Dec 2018

Excess weight responsible for cancers globally finds report

According to a new report published this week, excess body weight is one of the major reasons behind cancers worldwide. The report written by scientists at the American Cancer Society (ACS) and published in the journal CA: A Cancer Journal for Clinicians shows that 3.9 percent of the cases of cancers were linked to excess body weight and this amounted to 544,300 cases in 2012.

16 Dec 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of radiation following surgery, according to results from the world's longest running trial to investigate this.

5 Nov 2018

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte, Inc. announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

8 Oct 2018

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced that the China National Medical Products Administration approved the kinase inhibitor LENVIMA (lenvatinib) as a single agent for the treatment of patients with unresectable hepatocellular carcinoma who have not received prior systemic therapy.

24 Sep 2018

Endocrine Society announces winners of prestigious 2019 Laureate Awards

The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2019 Laureate Awards, the top honors in the field.

6 Sep 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Removing the cancer label - overhaul in cancer classification proposed

Australian researchers have asked for changes in the way doctors tend to label low risk cancerous conditions as “cancer” leading to over treatment. Certain diagnoses such as localised prostate cancer or “stage 0” breast cancers need to be looked at say the researchers at the University of Sydney and Bond University to prevent aggressive treatment where it is not needed.

12 Aug 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Cancer mortality at an all time low finds report

Study: Type 2 diabetes linked to elevated risk of several cancers

Pediatric patients undergoing thyroid surgery have better outcomes at high-volume centers

Breakthrough alpha-ray treatment of iodine-refractory thyroid cancer with multiple metastases

Study highlights debt and work-related impairments for young adult cancer survivors

An essential reference for diagnostic ultrasonography and biopsy of the thyroid gland

Study: Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors

Excess weight responsible for cancers globally finds report

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

Low risk thyroid cancer patients can be treated with smaller amount of radiation, suggests study

Head and neck cancer survivors more likely to commit suicide

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

Endocrine Society announces winners of prestigious 2019 Laureate Awards

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Removing the cancer label - overhaul in cancer classification proposed

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Experts highlight the need to avoid overdiagnosis and 'excessive' treatment of thyroid cancer

MicroRNA panel could categorize indeterminate thyroid nodule samples into malignant and benign

Study shows increased risk of cancer among US flight attendants

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in